Global site navigation

Apple hit again with US ban in watch patent feud
Business and Economy

Apple hit again with US ban in watch patent feud

by  AFP 1 min read
An Apple Watch 9 displays blood-oxygen level detection settings
An Apple Watch 9 displays blood-oxygen level detection settings. Photo: Chris DELMAS / AFP/File
Source: AFP

PAY ATTENTION: Follow YEN's WhatsApp channel for a daily dose of breaking news on the go!

A federal appeals court on Wednesday ordered Apple to halt the US sale of its latest smartwatch models in a feud over patents with health company Masimo.

The ban on certain Apple smartwatch models will come into effect Thursday as the iPhone juggernaut is ordered to await the outcome of its appeal.

Masimo, based in southern California, filed a complaint to the US International Trade Commission (ITC) which decided in October to halt imports of the Apple Watch models over a patented technology for detecting blood-oxygen levels.

A court temporarily lifted the ban last month.

Apple manufactures the vast majority of its products overseas, predominantly in China, giving the ITC jurisdiction over the patent feud.

According to reports, Apple is planning to remove the technology for now from the smartwatches in question -- the Series 9 and Ultra 2 -- in a solution that Masimo has welcomed.

Read also

Apple ends Samsung's 12-year run as world's top smartphone seller

PAY ATTENTION: Сheck out news that is picked exactly for YOU ➡️ click on “Recommended for you” and enjoy!

Masimo contends it invented the technology and that Apple poached key employees to win access to the know-how.

But the iPhone-maker contends that the ITC finding was in error and should be reversed, and appealed the decision in the federal appeals court.

The wait for that decision could reportedly last a year or more.

Masimo and Apple did not immediately reply to a query from AFP.

Source: AFP

Authors:
AFP avatar

AFP AFP text, photo, graphic, audio or video material shall not be published, broadcast, rewritten for broadcast or publication or redistributed directly or indirectly in any medium. AFP news material may not be stored in whole or in part in a computer or otherwise except for personal and non-commercial use. AFP will not be held liable for any delays, inaccuracies, errors or omissions in any AFP news material or in transmission or delivery of all or any part thereof or for any damages whatsoever. As a newswire service, AFP does not obtain releases from subjects, individuals, groups or entities contained in its photographs, videos, graphics or quoted in its texts. Further, no clearance is obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP material. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP material.

Hot: